Immix Biopharma, Inc. in Los Angeles, CA, seeks a Senior CMC Technical Writer (Contract) to author and edit Module 3 and QOS for the first BLA for NXC-201. You will translate source data into regulatory content and coordinate with SMEs and CDMOs to meet filing timelines.
Requirements include CAR-T/CMC cell therapy experience, direct Module 3 authoring for a submitted FDA BLA, and a life sciences or engineering degree. 6-month contract, hybrid or remote, with $100–$150/hr.
#J-18808-LjbffrSenior CMC Writer – Cell Therapy & BLA (Contract, Remote) in los angeles at Unknown Company
This position is listed as contract and able to be worked remotely.